CONMED Corp. Stock
CONMED Corp. Stock
We can see a decrease in the price for CONMED Corp.. Compared to yesterday it has lost -€0.400 (-1.030%).
Currently there is a rather positive sentiment for CONMED Corp. with 3 Buy predictions and 0 Sell predictions.
With a target price of 53 € there is a positive potential of 37.31% for CONMED Corp. compared to the current price of 38.6 €.
Pros and Cons of CONMED Corp. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of CONMED Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| CONMED Corp. | -1.030% | 1.042% | 17.576% | -31.930% | 10.857% | -56.889% | -61.584% |
| Haemonetics Corp. | 0.910% | 4.762% | -1.786% | - | -19.708% | - | - |
| Bio-Rad Labs Inc. A | -1.340% | 5.141% | -5.115% | -9.253% | -7.212% | -49.536% | -51.163% |
| Neogen Corp. | -0.520% | -1.036% | 9.770% | -1.546% | 55.285% | - | - |
Comments
CONMED (NYSE:CNMD) had its price target lowered by analysts at Piper Sandler from $68.00 to $55.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat
CONMED Corporation (NYSE: CNMD) had its price target lowered by analysts at Piper Sandler from $80.00 to $68.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Needham & Company LLC from $91.00 to $61.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat